Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
2.480
+0.130 (5.53%)
May 12, 2025, 4:00 PM - Market closed
Achieve Life Sciences Employees
Achieve Life Sciences had 25 employees as of December 31, 2024. The number of employees increased by 3 or 13.64% compared to the previous year.
Employees
25
Change (1Y)
3
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$1,593,080
Market Cap
86.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ACHV News
- 6 days ago - Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 - GlobeNewsWire
- 21 days ago - Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine - GlobeNewsWire
- 2 months ago - Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program - GlobeNewsWire
- 2 months ago - Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 - GlobeNewsWire
- 3 months ago - Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference - GlobeNewsWire
- 3 months ago - Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial - GlobeNewsWire